Subacute but not acute generation of nitric oxide in focal cerebral ischemia

Stroke

Volumn 31, Issue 9, 2000, Pages 2208-2211

  Fassbender, K ^a   Fatar, M ^a   Ragoschke, A ^a   Picard, M ^a   Bertsch, T ^a   Kuehl, S ^a   Hennerici, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cerebral ischemia, focal; Nitric oxide; Nitric oxide synthase; Rats

Indexed keywords

AMINOGUANIDINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ACTIVITY; MALE; MICRODIALYSIS; MIDDLE CEREBRAL ARTERY; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

EID: 0033811099     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.9.2208     Document Type: Article

References (31)

1. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures
2. Apparent hydroxy radical production by peroxynitrite: Implications for endothelial cell injury from nitric oxide and superoxide
3. Redox signaling: Nitrosylation and related target interactions of nitric oxide
4. Bright and dark sides of nitric oxide in ischemic brain damage
5. Nitric oxide in acute ischaemic stroke: A target for neuroprotection
6. Neuroprotectants in late clinical development: A status report
7. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity
8. Brain nitrite production during global ischemia and reperfusion: An in vivo microdialysis study
9. Consecutive in vivo measurement of nitric oxide in transient forebrain ischemic brain under normothermia and hypothermia
10. Consecutive evaluation of nitric oxide production after transient cerebral ischemia in the rat hippocampus using in vivo brain microdialysis
11. Nitric oxide production in the CA1 field of the gerbil hippocampus after transient forebrain ischemia: Effects of 7-nitroindazole and N(G)-nitro-L-arginine methyl ester
12. Nitric oxide production during focal cerebral ischemia in rats
13. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats
14. Brain microdialysis
15. Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion
16. Reversible middle cerebral artery occlusion without craniectomy in rats
17. Subacute NO generation induced by Alzheimer's β-amyloid in the living brain: Reversal by inhibition of the inducible NO synthase
18. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage
19. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination
20. Cerebral ischemia, II: The no-reflow phenomenon
21. Calcium-independent NO-synthase activity and nitrites/nitrates production in transient focal ischaemia in mice
22. Polymorphonuclear leukocytes and monocytes/macro-phages in the pathogenesis of cerebral ischemia and stroke
23. Influx of leukocytes and platelets in an evolving brain infarct (Wistar rat)
24. Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: An FAD- and FMN-containing flavoprotein
25. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat
26. Post-treatment with aminoguanidine reduces cerebral ischemic damage and neurological deficits in rats with middle cerebral artery occlusion
27. Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion
28. Inhibition of nitric oxide synthesis increases focal ischemic infarction in rat
29. Neither L-arginine nor L-NAME affects neurological outcome after global ischemia in cats
30. Inhibition of nitric oxide synthase does not reduce infarct volume in a rat model of focal cerebral ischemia